Table 1.

Phase 2 impact on GI

Formulation	GI	% Change from white bread control	P Value
Control	59.3 ± 24.7
1500 mg Capsule	61.9 ± 2.6	-4.39	0.77
2000 mg Capsule	45.1 ± 14.2	24.01	0.076
3000 mg Capsule	46.8 ± 12.5	21.05	0.11
1500 mg Powder	43.6 ± 15.7	26.41	0.11
2000 mg Powder	45.2 ± 14.1	23.76	0.16
3000 mg Powder	39.1 ± 20.2	34.11	0.023

The GI of white bread control compared to the GI of white bread plus different doses and formulations of Phase 2. GI values are presented as mean ± SD, n = 13. P values are the result of comparisons between the control and treatment values.